New COPD inhalers

Sandoz recently launched AirFluSal Forspiro (fluticasone propionate plus salmeterol), a new twice-daily dry powder inhaler (DPI) for the treatment of COPD.

The company says that Forspiro offers several features that make the device easy to use and aid compliance, including a dose counter; a window showing empty blisters; a tear-off foil strip enabling patients to ensure they have taken two doses per day; and a simple lever arm to load the dose.

Meanwhile, Chiesi’s DPI Fostair NEXThaler (beclomethasone and formoterol) has been granted a licence extension for patients with severe COPD and a history of repeated exacerbations, who have significant symptoms despite regular long-acting bronchodilators.

Again, the manufacturer says the device has several features that improve adherence. For example, Chiesi points out that, “whereas dose counters on other dry powder ICS/LABA combination products record the number of times the device has been primed or loaded, the dose counter on the NEXThaler device decreases only after successful inhalation”.

Latest discussions

  1. Pre reg exams

    Thanks for your comments both - Richard ...

  2. Pre reg exams

    Having been qualified just over 40 years...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.